ReviewFrontiers in immunology2026
Research progress in the inhibitory mechanisms of traditional Chinese medicine therapies against influenza A.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza A, an acute or subacute respiratory infectious disease caused by the influenza A virus (IAV), affects humans and animals, and poses a serious threat to public health. Currently, IAV prevention and treatment rely primarily on antiviral drugs and nebulization therapy. Although these methods offer rapid efficacy, prolonged or excessive use often induces drug resistance and sequelae, and has high costs. Throughout China's history, traditional Chinese medicine (TCM) has repeatedly resisted major epidemics, and substantially contributed to the survival and cultural continuity of the Chinese nation. Modern medical research has demonstrated that certain traditional Chinese medicinal formulas or their primary active constituents exhibit significant antiviral activity and immunomodulatory effects. Consequently, exploring the antiviral mechanisms of TCM or their active components, alongside their synergistic application with influenza vaccines and existing antiviral drugs, could enable novel approaches and research directions to achieve influenza prevention and control. This article reviews the current status of IAV transmission, as well as progress in modern medical research in influenza A prevention and treatment with TCMs or their active constituents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.